register

News & Trends - Pharmaceuticals

Testosterone replacement therapy to benefit male cancer survivors

Health Industry Hub | November 27, 2019 |

Testosterone replacement is associated with an improvement in body composition among younger male cancer survivors with low-normal morning total serum testosterone, according to a new study.

Low testosterone in cancer survivors can be due to orchidectomy or effects of chemotherapy and radiotherapy. The researchers invited young male cancer survivors aged 25–50 years with borderline low testosterone levels
(7–12 nmol/l) to participate in a placebo-controlled double-blind trial of testosterone replacement therapy.

At 6 months, the young male cancer survivors treated with testosterone had a decrease in their fat mass, on average, of 1.8 kg and an increase in lean mass of 1.5 kg.

Young adult survivors of childhood malignancy have an 8-fold-greater risk of cardiac mortality than the healthy population, and cardiovascular morbidity is one of the commonest late effects seen in cancer survivors.

A young male cancer survivor with a borderline low morning testosterone level may benefit from testosterone replacement, with an improvement in body composition with loss of fat mass and increase in muscle mass. This may potentially offset the risk of increased mortality from heart disease.

You may also like First atopic dermatitis biologic in Australia “merits conversation with patients”

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


Human Resources

The return-to-office debate: Where are we in the pendulum's swing?

The return-to-office debate: Where are we in the pendulum’s swing?

Health Industry Hub | May 24, 2024 |

People & Culture: The evolution of hybrid and flexible workplaces has yielded mixed results across the healthcare sector, with some […]

More


News & Trends - MedTech & Diagnostics

Cardinal Health launches local facility for reprocessing of single-use medical devices

Cardinal Health launches local facility for reprocessing of single-use medical devices

Health Industry Hub | May 24, 2024 |

MedTech & Diagnostics News: Cardinal Health is set to launch a cutting-edge facility in Australia dedicated to the reprocessing of […]

More


Medical

New ophthalmic centre to partner on pharma and medtech clinical trials

New ophthalmic centre to partner on pharma and medtech clinical trials

Health Industry Hub | May 24, 2024 |

Medical: The Victorian Deputy Premier and Minister for Medical Research, the Hon Ben Carroll, has launched a cutting-edge ophthalmic clinical […]

More


News & Trends - Pharmaceuticals

Private sector, government and academia gather to tackle barriers in vaccine value chain

Private sector, government and academia gather to tackle barriers in vaccine value chain

Health Industry Hub | May 24, 2024 |

Pharma News: An ‘invite only’ vaccine thought leadership event, aimed at addressing gaps in Australia’s vaccine ecosystem and maximising the […]

More


This content is copyright protected. Please subscribe to gain access.